Summary:
Study evaluating the safety and therapeutic value of an investigational medicine on pediatric Bipolar Mania / Mixed Disorder
Qualified Participants Must:
be between 11 and 18 years of age
have been diagnosed with bipolar disorder or meet diagnostic criteria when evaluated to participate in this study